Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Clinical trial NCT07451613 · RECRUITING

Trial details

NCT number: NCT07451613
Sponsor: Leslie Thompson
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2026-04-06
Primary completion: 2028-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.